Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Autophagy and oxidative stress in gliomas with IDH1 mutations.

Gilbert MR, Liu Y, Neltner J, Pu H, Morris A, Sunkara M, Pittman T, Kyprianou N, Horbinski C.

Acta Neuropathol. 2014 Feb;127(2):221-33. doi: 10.1007/s00401-013-1194-6. Epub 2013 Oct 23.

2.

A 29 year old woman with acute mental status changes.

Neltner J, Horbinski C.

Brain Pathol. 2013 Jul;23(4):479-82.

PMID:
23936918
3.

What do we know about IDH1/2 mutations so far, and how do we use it?

Horbinski C.

Acta Neuropathol. 2013 May;125(5):621-36. doi: 10.1007/s00401-013-1106-9. Epub 2013 Mar 20. Review.

4.

PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.

Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, Martinez-Lage M, Robinson AE, Yong WH, Cloughesy T, Lai A, Phillips HS, Marshall R, Mueller S, Haas-Kogan DA, Molinaro AM, Perry A.

Brain Pathol. 2013 Sep;23(5):565-73. doi: 10.1111/bpa.12043. Epub 2013 Mar 18.

5.

How molecular testing can help (and hurt) in the workup of gliomas.

Clark K, Voronovich Z, Horbinski C.

Am J Clin Pathol. 2013 Mar;139(3):275-88. doi: 10.1309/AJCPFO8IIDNBIJ8Y.

6.

To BRAF or not to BRAF: is that even a question anymore?

Horbinski C.

J Neuropathol Exp Neurol. 2013 Jan;72(1):2-7. doi: 10.1097/NEN.0b013e318279f3db. Review.

7.

Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.

Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM.

Cancer Res. 2013 Jan 15;73(2):1011-9. doi: 10.1158/0008-5472.CAN-12-3212. Epub 2012 Nov 30.

Supplemental Content

Loading ...
Support Center